Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
 
 
 
This Media Center provides you with the latest news about our Oncology Franchise and related disease information.

  
 

Media Center - Oncology

Media Fact Sheets

TopicDownload
Gastroesophageal Junction CancerPDF
Ovarian CancerPDF
Merkel Cell CarcinomaPDF
Gastric cancerPDF
Bladder CancerPDF
Lung cancerPDF
Renal cell carcinomaPDF
MesotheliomaPDF
Following media fact sheets are available on request.
  • Avelumab
.
top

Animations

Gastric Cancer: Signs and Symptoms
Gastric Cancer: Signs and Symptoms
Lung Cancer: Facts and Figures
Lung Cancer: Facts and Figures
Merkel Cell Carcinoma: Facts and Figures
Merkel Cell Carcinoma: Facts and Figures
Merkel Cell Carcinoma: Signs and Symptoms
Merkel Cell Carcinoma: Signs and Symptoms
Ovarian Cancer: Facts and Symptoms
Ovarian Cancer: Facts and Symptoms
Renal Cell Carcinoma: Facts and Symptoms
Renal Cell Carcinoma: Facts and Symptoms
Malignant Mesothelioma: Facts and Figures
Malignant Mesothelioma: Facts and Figures
.
top

Images

AVELUMAB MOLECULE

Avelumab molecule
.
top

News Releases Oncology

Follow the link to read more

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.
 

CONTACT

Are you interested in interviewing a internal spokesperson or an oncology expert? Please get in contact with us.
Gangolf Schrimpf
GANGOLF SCHRIMPF
Tel: +49 6151 72-9591
Fax: +49 6151 72-919591